Steve Hulme's most recent trade in Ingevity Corp was a trade of 278 Common Stock done at an average price of $47.7 . Disclosure was reported to the exchange on Feb. 28, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Ingevity Corp | Steve Hulme | SVP and Pres, APT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.66 per share. | 28 Feb 2025 | 278 | 3,309 (0%) | 0% | 47.7 | 13,249 | Common Stock |
Ingevity Corp | Steve Hulme | SVP and Pres, APT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.66 per share. | 28 Feb 2025 | 152 | 3,587 (0%) | 0% | 47.7 | 7,244 | Common Stock |
Ingevity Corp | Steve Hulme | SVP and Pres, APT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.66 per share. | 28 Feb 2025 | 104 | 3,205 (0%) | 0% | 47.7 | 4,957 | Common Stock |
Ingevity Corp | Steve Hulme | SVP and Pres, APT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.66 per share. | 28 Feb 2025 | 94 | 3,739 (0%) | 0% | 47.7 | 4,480 | Common Stock |
Ingevity Corp | Steve Hulme | SVP and Pres, APT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 336 | 3,991 (0%) | 0% | 0 | Common Stock | |
Ingevity Corp | Steve Hulme | SVP and Pres, APT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.26 per share. | 19 Feb 2025 | 158 | 3,833 (0%) | 0% | 48.3 | 7,625 | Common Stock |
Ingevity Corp | Steve Hulme | SVP and Pres, APT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 1,768 | 2,992 (0%) | 0% | 0 | Common Stock | |
Ingevity Corp | Steve Hulme | SVP and Pres, APT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 663 | 3,655 (0%) | 0% | 0 | Common Stock | |
Ingevity Corp | Steve Hulme | SVP and Pres, APT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.27 per share. | 28 Feb 2024 | 153 | 1,224 (0%) | 0% | 45.3 | 6,926 | Common Stock |
Ingevity Corp | Steve Hulme | SVP and Pres, APT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.27 per share. | 28 Feb 2024 | 94 | 1,377 (0%) | 0% | 45.3 | 4,255 | Common Stock |
Ingevity Corp | Steve Hulme | SVP, Perf Chem and Pres, EP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 970 | 1,471 (0%) | 0% | 0 | Common Stock | |
Ingevity Corp | Steve Hulme | SVP, Perf Chem and Pres, EP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.56 per share. | 28 Feb 2023 | 98 | 501 (0%) | 0% | 82.6 | 8,091 | Common Stock |
Ingevity Corp | Steve Hulme | SVP, Perf Chem and Pres, EP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 1,464 | 1,464 | - | - | Common Stock | |
Ingevity Corp | Steve Hulme | SVP, Perf Chem and Pres, EP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 599 | 599 (0%) | 0% | 0 | Common Stock |